Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 66 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8669081

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  2. US 8669249

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  3. US 8664251

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  4. US 8664219

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  5. US 8658669

    Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  6. US 8653070

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  7. US 8653088

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  8. US 8648037

    Macrocyclic proline derived HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  9. US 8642282

    Inhibitors of nitric oxide synthase for treatment of melanoma

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  10. US 8642779

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  11. US 8642751

    MicroRNA inhibitors comprising locked nucleotides

    MIRAGEN THERAPEUTICS, INC. · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  12. US 8637675

    Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)

    The Board of Regents of the University of Texas System · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  13. US 8637666

    Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  14. US 8637568

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  15. US 8637511

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  16. US 8633210

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  17. US 8633205

    Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  18. US 8629156

    Tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  19. US 8623867

    Cyclic amine BACE-1 inhibitors having a benzamide substituent

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  20. US 8623869

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  21. US 8618152

    Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases

    Vertex Pharmaceuticals Incorporated · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  22. US 8618090

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  23. US 8618331

    Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  24. US 8618290

    HSP90 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.